Fenofibrate Dosing and Administration
Dosing Considerations
- For patients with mild to moderate renal impairment, the initial dose of fenofibrate should be 54 mg per day, with a maximum of 54 mg daily, and renal function should be evaluated before initiating therapy, within 3 months after initiation, and every 6 months thereafter, as recommended by the guideline society, with a strength of evidence not specified 1
- If eGFR decreases persistently to <30 mL/min/1.73m², fenofibrate should be discontinued, according to the guideline society, with a strength of evidence not specified 1
Administration Considerations
- Fenofibrate can be administered at any time of day, as there is no specific time requirement that impacts its efficacy, and if combined with bile acid sequestrants, fenofibrate should be taken either ≥2 hours before or ≥4 hours after the bile acid sequestrant to avoid interference with absorption, as recommended by the guideline society, with a strength of evidence not specified 2
Combination Therapy Considerations
- When combined with statins, there is an increased risk of muscle symptoms and rhabdomyolysis, and if combination therapy is necessary, use with low or moderate-intensity statins only, as recommended by the guideline society, with a strength of evidence not specified 1
- For patients who cannot tolerate fenofibrate, gemfibrozil may be an alternative, though it has different dosing (600 mg twice daily), according to the Clinical Infectious Diseases guideline, with a strength of evidence not specified 3